All I really know is that it's a "bet your company" type project - huge development costs and huge potential reward.
This is not a space where I have any real (or even imaginary :) ) expertise, so I'll leave it to Dew and others to debate the risk/reward ratio of the drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.